Elicio Therapeutics Inc.
ELTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$54.15M
Close$
$0.26
89.4% downside
Current Fair Value
89.4% downsideOvervalued by 89.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $54.15 Million |
|---|---|
| Enterprise Value | $35.28 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.58 |
| Beta | 1.88 |
| Outstanding Shares | 19,244,679 |
Return
| Return on Equity | -476.77% |
|---|---|
| Return on Assets | -120.78% |
| Return on Invested Capital | -183.86% |
Valuation & Multiples
| P/E Ratio | -1.33 |
|---|---|
| PEG | 6.01 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.87 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.58 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.54
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.52
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2152▼ 874.22% |
|---|---|
| Total Calls | 405,200▲ 1051.14% |
| Total Puts | 87,200▼ 72.34% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 14.50%▲ 0.91% |
|---|---|
| Total Invested | $28.22M▲ 70.47% |
| Investors Holding | 53▲ 13.00% |
ESG Score
No data
About Elicio Therapeutics Inc
2,021 employees